Annual SG&A
$1.82 B
+$256.90 M+16.40%
31 December 2023
Summary:
Edwards Lifesciences annual selling, general & administrative expenses is currently $1.82 billion, with the most recent change of +$256.90 million (+16.40%) on 31 December 2023. During the last 3 years, it has risen by +$329.40 million (+22.05%). EW annual SG&A is now at all-time high.EW Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$421.40 M
-$29.40 M-6.52%
30 September 2024
Summary:
Edwards Lifesciences quarterly selling, general & administrative expenses is currently $421.40 million, with the most recent change of -$29.40 million (-6.52%) on 30 September 2024. Over the past year, it has dropped by -$58.60 million (-12.21%). EW quarterly SG&A is now -13.95% below its all-time high of $489.70 million, reached on 31 March 2024.EW Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
$40.83 B
+$4.16 B+11.34%
30 September 2024
Summary:
Edwards Lifesciences TTM selling, general & administrative expenses is currently $40.83 billion, with the most recent change of +$4.16 billion (+11.34%) on 30 September 2024. Over the past year, it has increased by +$39.06 billion (+2211.54%). EW TTM SG&A is now at all-time high.EW TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EW Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -12.2% | +2211.5% |
| 3 y3 years | +22.1% | -0.6% | +2633.4% |
| 5 y5 years | +46.8% | +21.4% | +3186.8% |
EW Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +22.1% | -13.9% | +13.8% | at high | +84.8% |
| 5 y | 5 years | at high | +48.4% | -13.9% | +53.3% | at high | +206.2% |
| alltime | all time | at high | +798.2% | -13.9% | +808.2% | at high | >+9999.0% |
Edwards Lifesciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $421.40 M(-6.5%) | $1.84 B(-1.0%) |
| June 2024 | - | $450.80 M(-7.9%) | $1.86 B(+2.2%) |
| Mar 2024 | - | $489.70 M(+2.0%) | $1.82 B(+3.0%) |
| Dec 2023 | $1.82 B(+16.4%) | $480.00 M(+9.2%) | $1.77 B(+4.1%) |
| Sept 2023 | - | $439.60 M(+7.1%) | $1.70 B(+3.8%) |
| June 2023 | - | $410.40 M(-5.9%) | $1.64 B(+0.1%) |
| Mar 2023 | - | $436.30 M(+6.2%) | $1.63 B(+4.2%) |
| Dec 2022 | $1.57 B(+4.9%) | $411.00 M(+8.9%) | $1.57 B(-0.8%) |
| Sept 2022 | - | $377.30 M(-7.8%) | $1.58 B(+0.8%) |
| June 2022 | - | $409.00 M(+10.5%) | $1.57 B(+2.3%) |
| Mar 2022 | - | $370.30 M(-12.7%) | $1.53 B(+2.6%) |
| Dec 2021 | $1.49 B(+21.6%) | $424.00 M(+16.4%) | $1.49 B(+6.1%) |
| Sept 2021 | - | $364.40 M(-2.7%) | $1.41 B(+4.2%) |
| June 2021 | - | $374.50 M(+13.2%) | $1.35 B(+8.0%) |
| Mar 2021 | - | $330.80 M(-2.3%) | $1.25 B(+1.9%) |
| Dec 2020 | $1.23 B(-1.1%) | $338.50 M(+10.2%) | $1.23 B(-0.7%) |
| Sept 2020 | - | $307.20 M(+11.7%) | $1.24 B(+0.1%) |
| June 2020 | - | $274.90 M(-10.7%) | $1.24 B(-2.6%) |
| Mar 2020 | - | $307.80 M(-11.3%) | $1.27 B(+2.2%) |
| Dec 2019 | $1.24 B(+14.1%) | $347.20 M(+13.4%) | $1.24 B(+5.0%) |
| Sept 2019 | - | $306.20 M(-0.7%) | $1.18 B(+3.2%) |
| June 2019 | - | $308.50 M(+10.1%) | $1.15 B(+3.0%) |
| Mar 2019 | - | $280.30 M(-2.7%) | $1.11 B(+2.2%) |
| Dec 2018 | $1.09 B(+9.9%) | $288.10 M(+6.9%) | $1.09 B(+1.4%) |
| Sept 2018 | - | $269.50 M(-2.0%) | $1.07 B(+2.4%) |
| June 2018 | - | $274.90 M(+7.4%) | $1.05 B(+3.1%) |
| Mar 2018 | - | $256.00 M(-6.2%) | $1.02 B(+2.7%) |
| Dec 2017 | $990.80 M(+9.5%) | $272.80 M(+11.5%) | $990.80 M(+4.1%) |
| Sept 2017 | - | $244.60 M(+0.3%) | $951.60 M(+1.6%) |
| June 2017 | - | $243.80 M(+6.2%) | $936.60 M(+1.6%) |
| Mar 2017 | - | $229.60 M(-1.7%) | $921.60 M(+1.9%) |
| Dec 2016 | $904.70 M(+6.3%) | $233.60 M(+1.7%) | $904.70 M(+1.3%) |
| Sept 2016 | - | $229.60 M(+0.3%) | $893.40 M(+2.0%) |
| June 2016 | - | $228.80 M(+7.6%) | $875.80 M(+1.7%) |
| Mar 2016 | - | $212.70 M(-4.3%) | $860.90 M(+1.2%) |
| Dec 2015 | $850.70 M(-0.9%) | $222.30 M(+4.9%) | $850.70 M(-0.1%) |
| Sept 2015 | - | $212.00 M(-0.9%) | $851.50 M(-1.2%) |
| June 2015 | - | $213.90 M(+5.6%) | $861.70 M(-0.2%) |
| Mar 2015 | - | $202.50 M(-9.2%) | $863.30 M(+0.6%) |
| Dec 2014 | $858.00 M(+17.0%) | $223.10 M(+0.4%) | $858.00 M(+4.4%) |
| Sept 2014 | - | $222.20 M(+3.1%) | $821.50 M(+5.7%) |
| June 2014 | - | $215.50 M(+9.3%) | $777.10 M(+3.9%) |
| Mar 2014 | - | $197.20 M(+5.7%) | $748.20 M(+2.0%) |
| Dec 2013 | $733.40 M(+5.2%) | $186.60 M(+4.9%) | $733.40 M(+2.3%) |
| Sept 2013 | - | $177.80 M(-4.7%) | $716.80 M(+1.4%) |
| June 2013 | - | $186.60 M(+2.3%) | $706.80 M(+0.6%) |
| Mar 2013 | - | $182.40 M(+7.3%) | $702.60 M(+0.7%) |
| Dec 2012 | $697.40 M | $170.00 M(+1.3%) | $697.40 M(+1.0%) |
| Sept 2012 | - | $167.80 M(-8.0%) | $690.80 M(+0.3%) |
| June 2012 | - | $182.40 M(+2.9%) | $688.50 M(+2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $177.20 M(+8.4%) | $669.30 M(+4.2%) |
| Dec 2011 | $642.40 M(+16.8%) | $163.40 M(-1.3%) | $642.40 M(+3.4%) |
| Sept 2011 | - | $165.50 M(+1.4%) | $621.40 M(+5.5%) |
| June 2011 | - | $163.20 M(+8.6%) | $588.90 M(+4.0%) |
| Mar 2011 | - | $150.30 M(+5.5%) | $566.30 M(+3.0%) |
| Dec 2010 | $550.00 M(+8.1%) | $142.40 M(+7.1%) | $550.00 M(+1.9%) |
| Sept 2010 | - | $133.00 M(-5.4%) | $539.90 M(+1.3%) |
| June 2010 | - | $140.60 M(+4.9%) | $533.00 M(+2.3%) |
| Mar 2010 | - | $134.00 M(+1.3%) | $520.90 M(+2.4%) |
| Dec 2009 | $508.80 M(+5.9%) | $132.30 M(+4.9%) | $508.80 M(+2.4%) |
| Sept 2009 | - | $126.10 M(-1.9%) | $496.70 M(+1.4%) |
| June 2009 | - | $128.50 M(+5.4%) | $489.90 M(+0.4%) |
| Mar 2009 | - | $121.90 M(+1.4%) | $487.90 M(+1.5%) |
| Dec 2008 | $480.60 M(+15.0%) | $120.20 M(+0.8%) | $480.60 M(+1.2%) |
| Sept 2008 | - | $119.30 M(-5.7%) | $474.90 M(+3.5%) |
| June 2008 | - | $126.50 M(+10.4%) | $458.80 M(+5.7%) |
| Mar 2008 | - | $114.60 M(+0.1%) | $434.00 M(+3.8%) |
| Dec 2007 | $418.00 M(+11.2%) | $114.50 M(+10.9%) | $418.00 M(+4.9%) |
| Sept 2007 | - | $103.20 M(+1.5%) | $398.60 M(+3.0%) |
| June 2007 | - | $101.70 M(+3.1%) | $387.10 M(+1.2%) |
| Mar 2007 | - | $98.60 M(+3.7%) | $382.40 M(+1.8%) |
| Dec 2006 | $376.00 M(+7.7%) | $95.10 M(+3.7%) | $375.80 M(+2.1%) |
| Sept 2006 | - | $91.70 M(-5.5%) | $368.10 M(+1.6%) |
| June 2006 | - | $97.00 M(+5.4%) | $362.30 M(+1.9%) |
| Mar 2006 | - | $92.00 M(+5.3%) | $355.40 M(+1.8%) |
| Dec 2005 | $349.00 M(+9.1%) | $87.40 M(+1.7%) | $349.00 M(+1.4%) |
| Sept 2005 | - | $85.90 M(-4.7%) | $344.30 M(+1.8%) |
| June 2005 | - | $90.10 M(+5.3%) | $338.10 M(+2.8%) |
| Mar 2005 | - | $85.60 M(+3.5%) | $329.00 M(+2.8%) |
| Dec 2004 | $319.90 M(+10.3%) | $82.70 M(+3.8%) | $319.90 M(+3.4%) |
| Sept 2004 | - | $79.70 M(-1.6%) | $309.40 M(+3.1%) |
| June 2004 | - | $81.00 M(+5.9%) | $300.20 M(+1.8%) |
| Mar 2004 | - | $76.50 M(+6.0%) | $295.00 M(+1.8%) |
| Dec 2003 | $289.90 M(+27.2%) | $72.20 M(+2.4%) | $289.90 M(+1.2%) |
| Sept 2003 | - | $70.50 M(-7.0%) | $286.40 M(+6.0%) |
| June 2003 | - | $75.80 M(+6.2%) | $270.10 M(+8.6%) |
| Mar 2003 | - | $71.40 M(+3.9%) | $248.60 M(+9.1%) |
| Dec 2002 | $227.90 M(+12.3%) | $68.70 M(+26.8%) | $227.90 M(+8.9%) |
| Sept 2002 | - | $54.20 M(-0.2%) | $209.30 M(+3.9%) |
| June 2002 | - | $54.30 M(+7.1%) | $201.50 M(+0.8%) |
| Mar 2002 | - | $50.70 M(+1.2%) | $199.90 M(-1.5%) |
| Dec 2001 | $203.00 M(-6.0%) | $50.10 M(+8.0%) | $203.00 M(-3.6%) |
| Sept 2001 | - | $46.40 M(-12.0%) | $210.50 M(-0.1%) |
| June 2001 | - | $52.70 M(-2.0%) | $210.70 M(-2.9%) |
| Mar 2001 | - | $53.80 M(-6.6%) | $217.00 M(-2.8%) |
| Dec 2000 | $216.00 M(-7.3%) | $57.60 M(+23.6%) | $223.20 M(+34.8%) |
| Sept 2000 | - | $46.60 M(-21.0%) | $165.60 M(+39.2%) |
| June 2000 | - | $59.00 M(-1.7%) | $119.00 M(+98.3%) |
| Mar 2000 | - | $60.00 M | $60.00 M |
| Dec 1999 | $233.00 M | - | - |
FAQ
- What is Edwards Lifesciences annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly SG&A year-on-year change?
- What is Edwards Lifesciences TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Edwards Lifesciences?
- What is Edwards Lifesciences TTM SG&A year-on-year change?
What is Edwards Lifesciences annual selling, general & administrative expenses?
The current annual SG&A of EW is $1.82 B
What is the all time high annual SG&A for Edwards Lifesciences?
Edwards Lifesciences all-time high annual selling, general & administrative expenses is $1.82 B
What is Edwards Lifesciences quarterly selling, general & administrative expenses?
The current quarterly SG&A of EW is $421.40 M
What is the all time high quarterly SG&A for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly selling, general & administrative expenses is $489.70 M
What is Edwards Lifesciences quarterly SG&A year-on-year change?
Over the past year, EW quarterly selling, general & administrative expenses has changed by -$58.60 M (-12.21%)
What is Edwards Lifesciences TTM selling, general & administrative expenses?
The current TTM SG&A of EW is $40.83 B
What is the all time high TTM SG&A for Edwards Lifesciences?
Edwards Lifesciences all-time high TTM selling, general & administrative expenses is $1.86 B
What is Edwards Lifesciences TTM SG&A year-on-year change?
Over the past year, EW TTM selling, general & administrative expenses has changed by +$39.06 B (+2211.54%)